Literature DB >> 2172284

Detection of Epstein-Barr virus by polymerase chain reaction.

A Telenti1, W F Marshall, T F Smith.   

Abstract

The polymerase chain reaction (PCR) was used to study DNA extracted from the blood of 25 transplant patients, 5 patients with infectious mononucleosis, and 13 healthy subjects and autopsy or biopsy tissue from 29 patients with lymphoproliferative disorders. Primers were directed to conserved regions of the Epstein-Barr virus (EBV) genome encoding capsid protein gp220 and Epstein-Barr nuclear antigen 1. Specific EBV amplification was found in the blood of 11 of 25 transplant patients and all patients with infectious mononucleosis. All patients with lymphoproliferative disorders occurring in the presence of immunosuppression (eight organ transplant patients and two patients with acquired immunodeficiency syndrome) had biopsies positive for EBV by PCR. Only 1 of 19 samples from lymphomas or leukemias unrelated to immunosuppression contained EBV. PCR confirmed the very close association of EBV and lymphoproliferative disorders occurring in the presence of immunosuppression. The significance of detecting EBV sequences in the blood of transplant patients, particularly in relationship to lymphoproliferation, requires further study.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172284      PMCID: PMC268144          DOI: 10.1128/jcm.28.10.2187-2190.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

Review 1.  Polymerase chain reaction.

Authors:  G Schochetman; C Y Ou; W K Jones
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

2.  Limitations of available tests for diagnosis of infectious mononucleosis.

Authors:  G R Fleisher; M Collins; S Fager
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

3.  Small noncleaved B cell Burkitt-like lymphoma with chromosome t(8;14) translocation and Epstein-Barr virus nuclear-associated antigen in a homosexual man with acquired immune deficiency syndrome.

Authors:  J M Petersen; R R Tubbs; R A Savage; L C Calabrese; M R Proffitt; Y Manolova; G Manolov; A Shumaker; E Tatsumi; K McClain
Journal:  Am J Med       Date:  1985-01       Impact factor: 4.965

4.  Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders.

Authors:  D L Birx; R R Redfield; G Tosato
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

5.  The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression.

Authors:  M A Nalesnik; R Jaffe; T E Starzl; A J Demetris; K Porter; J A Burnham; L Makowka; M Ho; J Locker
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

Review 6.  Epstein-Barr virus and human diseases: recent advances in diagnosis.

Authors:  M Okano; G M Thiele; J R Davis; H L Grierson; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

7.  Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody.

Authors:  P J Martin; H M Shulman; W H Schubach; J A Hansen; A Fefer; G Miller; E D Thomas
Journal:  Ann Intern Med       Date:  1984-09       Impact factor: 25.391

8.  Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis.

Authors:  G Rocchi; A Felici; G Ragona; A Heinz
Journal:  N Engl J Med       Date:  1977-01-20       Impact factor: 91.245

9.  Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection.

Authors:  M Ho; G Miller; R W Atchison; M K Breinig; J S Dummer; W Andiman; T E Starzl; R Eastman; B P Griffith; R L Hardesty
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

View more
  21 in total

1.  Development of a real-time quantitative assay for detection of Epstein-Barr virus.

Authors:  H G Niesters; J van Esser; E Fries; K C Wolthers; J Cornelissen; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.

Authors:  F Baldanti; P Grossi; M Furione; L Simoncini; A Sarasini; P Comoli; R Maccario; R Fiocchi; G Gerna
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction.

Authors:  H J Wagner; G Bein; A Bitsch; H Kirchner
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

Review 4.  Molecular biology made easy. The polymerase chain reaction.

Authors:  A M Clarke; N P Mapstone; P Quirke
Journal:  Histochem J       Date:  1992-12

5.  Association of autism with polyomavirus infection in postmortem brains.

Authors:  Carla Lintas; Laura Altieri; Federica Lombardi; Roberto Sacco; Antonio M Persico
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

6.  Detection of Epstein-Barr virus genome in peripheral leucocytes and CSF by the polymerase chain reaction in two patients with Epstein-Barr virus related to aseptic meningitis.

Authors:  M Kaji; H Shoji
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-07       Impact factor: 10.154

7.  Double-step PCR assay to quantify Epstein-Barr viral load in peripheral blood.

Authors:  Massimiliano Bergallo; Chiara Merlino; Roberta Daniele; Franca Sinesi; Mara Fumagalli; Alessandro Negro Ponzi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2004-07       Impact factor: 2.695

8.  Comparison of three methods for extraction of viral nucleic acids from blood cultures.

Authors:  M J Espy; R Patel; C V Paya; T F Smith
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

9.  Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.

Authors:  S Imai; S Koizumi; M Sugiura; M Tokunaga; Y Uemura; N Yamamoto; S Tanaka; E Sato; T Osato
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  Sample preparation method for polymerase chain reaction-based semiquantitative detection of Leptospira interrogans serovar hardjo subtype hardjobovis in bovine urine.

Authors:  M J Gerritsen; T Olyhoek; M A Smits; B A Bokhout
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.